By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


SRI International 

333 Ravenswood Avenue

Menlo Park  California  94025  U.S.A.
Phone: 866-451-5998 Fax: 650-859-2889


SRI International’s Biosciences Division carries out basic research, drug discovery and drug development, and provides contract services. SRI Biosciences has all of the resources necessary to take R&D from Idea to IND and Beyond™ —from initial discovery to human clinical trials—and specializes in cancer, immunology and inflammation, infectious disease, and neuroscience. SRI’s product pipeline has yielded marketed drugs, therapeutics currently in clinical trials, and additional programs in earlier stages. In its CRO business, SRI has helped government and other clients and partners advance well over 100 drugs into patient testing. SRI is also working to create the next generation of technologies in areas such as diagnostics, drug delivery, medical devices, and systems biology.

Key Statistics

Ownership: Private

Web Site: SRI International
Employees: n/a

Company News
SRI International Receives $9 Million Contract To Support National Cancer Institute PREVENT Cancer Program 11/3/2015 6:59:50 AM
SRI International Biosciences Researchers Part Of Team Reporting New Cancer Therapy Strategy In Nature 10/29/2015 7:35:15 AM
SRI International Awarded $40 Million NICHD Contract to Develop New Contraceptive Products 10/28/2015 6:14:34 AM
SRI International's Tumor Glycome Laboratory Finds Carbohydrate Biomarkers To Target Breast Cancers 10/22/2015 9:37:23 AM
SRI International Awarded $100 Million National Institute of Allergy And Infectious Diseases (NIAID) Contract To Develop Treatments For Radiation Exposure 10/7/2015 11:04:29 AM
Lux Research And SRI International Announce Strategic Innovation Partnership 9/30/2015 12:30:17 PM
SRI International Licenses DataSpeaks Software For Development Of A Virtual Clinical Decision-Making Assistant 9/9/2015 7:09:36 AM
SRI International To Develop Screening Device For Radiation Exposure 6/25/2015 9:33:10 AM
SRI International Names Luther Lau Chief Financial Officer 12/16/2014 7:53:47 AM
Peter Kant Joins SRI International As Executive Director Of SRI's Center For Science, Technology, And Economic Development 12/8/2014 8:39:01 AM